Chris Koopmans - 15 Jun 2023 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Signature
Christopher Koopmans by Blair Walters as Attorney-in-Fact
Issuer symbol
MRVL
Transactions as of
15 Jun 2023
Transactions value $
-$124,360
Form type
4
Filing time
20 Jun 2023, 18:37:27 UTC
Previous filing
26 May 2023
Next filing
18 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVL Common Stock Sale -$124,360 -2,000 -1.4% $62.18 135,982 15 Jun 2023 By Family Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/01/2022.
F2 Includes 600 shares acquired under the Marvell 2000 Employee Stock Purchase Plan on June 7, 2023.
F3 Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.